SMAD4 or TGFβRII deletion in KRASG12D transgenic mice dramatically increased tumour aggressiveness, with accelerated PanIN and PDAC development, suggesting cooperation between these genetic alterations and mutant KRAS[42-44]. Here, KRAS is linked to neoplasm.